Proteomics of hepatocellular carcinoma: serum vimentin as a surrogate marker for small tumors (<or=2 cm).

PubWeight™: 0.93‹?›

🔗 View Article (PMID 20121168)

Published in J Proteome Res on April 05, 2010

Authors

Stella Sun1, Ronnie T P Poon, Nikki P Lee, Chun Yeung, K L Chan, Irene O L Ng, Philip J R Day, John M Luk

Author Affiliations

1: Department of Surgery, University of Hong Kong, Hong Kong, China.

Articles citing this

Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci (2011) 3.80

Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122. J Biol Chem (2011) 1.11

Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study. Mol Cell Proteomics (2013) 1.09

Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review. Br J Cancer (2015) 1.01

Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines. J Neurooncol (2011) 0.94

Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways. Neuro Oncol (2013) 0.93

Identification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma. PLoS One (2013) 0.91

Clinical proteomics for liver disease: a promising approach for discovery of novel biomarkers. Proteome Sci (2010) 0.84

Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma. PLoS One (2011) 0.83

Immunodetection of cyclooxygenase-2 (COX-2) is restricted to tissue macrophages in normal rat liver and to recruited mononuclear phagocytes in liver injury and cholangiocarcinoma. Histochem Cell Biol (2011) 0.80

Prophylactic uses of integrin CD18-betaA peptide in a murine polymicrobial peritonitis model. World J Gastroenterol (2010) 0.76

Articles by these authors

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell (2006) 12.72

Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med (2013) 7.48

Gene expression patterns in human liver cancers. Mol Biol Cell (2002) 6.93

Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell (2008) 6.48

MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med (2009) 6.13

An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell (2008) 5.47

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int (2010) 5.02

Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet (2012) 4.07

Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. J Am Coll Cardiol (1985) 3.66

Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer (2009) 3.52

Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study. J Clin Oncol (2013) 3.45

Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification. Hepatology (2014) 3.31

Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis. Gastroenterology (2006) 3.29

Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg (2004) 3.27

Long-term survival analysis of pure laparoscopic versus open hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a single-center experience. Ann Surg (2013) 3.11

Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet (2006) 2.96

Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy. Gastroenterology (2006) 2.78

Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clin Cancer Res (2006) 2.32

11C-acetate and 18F-FDG PET/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspective. J Nucl Med (2013) 2.29

Simplifying the ALPPS procedure by the anterior approach. Ann Surg (2014) 2.22

Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma. Genome Res (2013) 2.12

Aedes aegypti (L.) and Aedes albopictus (Skuse) in Singapore City. 1. Distribution and density. Bull World Health Organ (1971) 2.08

Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma. Arch Surg (2011) 2.05

Identification of local and circulating cancer stem cells in human liver cancer. Hepatology (2008) 2.02

Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg (2011) 2.01

Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure. J Am Coll Cardiol (1987) 2.00

Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr (1997) 1.98

MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochem Biophys Res Commun (2010) 1.92

A prospective study to assess the frequency of familial clustering of congenital bicuspid aortic valve. J Am Coll Cardiol (1997) 1.88

High-intensity focused ultrasound for hepatocellular carcinoma: a single-center experience. Ann Surg (2011) 1.79

Biology of hepatocellular carcinoma. Ann Surg Oncol (2008) 1.78

Implication of negative results on a monoplane transesophageal echocardiographic study in patients with suspected infective endocarditis. J Am Coll Cardiol (1993) 1.78

Ischemia-reperfusion of small liver remnant promotes liver tumor growth and metastases--activation of cell invasion and migration pathways. Liver Transpl (2007) 1.69

microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma. Mol Syst Biol (2010) 1.69

Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway. Hepatology (2010) 1.66

Histopathological and adhesion formation after incision using ultrasonic vibrating scalpel and regular scalpel in the rat. Fertil Steril (1994) 1.66

Comparison of early endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in the management of acute biliary pancreatitis: a prospective randomized study. Clin Gastroenterol Hepatol (2005) 1.66

Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values. Proteomics (2006) 1.65

Aedes aegypti (L.) and Aedes albopictus (Skuse) in Singapore City. 2. Larval habitats. Bull World Health Organ (1971) 1.65

A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma. Ann Surg (2007) 1.63

Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Lett (2006) 1.59

Circulating microRNAs as specific biomarkers for breast cancer detection. PLoS One (2013) 1.57

Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression. PLoS One (2011) 1.56

Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma. Gut (2011) 1.56

Reliability and validity of the Chinese version of IPAQ (short, last 7 days). J Sci Med Sport (2006) 1.56

Life history shapes gene expression in salmonids. Curr Biol (2006) 1.55

External drainage of pancreatic duct with a stent to reduce leakage rate of pancreaticojejunostomy after pancreaticoduodenectomy: a prospective randomized trial. Ann Surg (2007) 1.54

Silver nanoparticles inhibit hepatitis B virus replication. Antivir Ther (2008) 1.53

From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now. Oncology (2007) 1.51

Survival analysis of high-intensity focused ultrasound therapy versus radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma. Ann Surg (2013) 1.51

Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study. BMJ Open (2012) 1.50

Molecular pathogenesis of hepatocellular carcinoma. Liver Int (2007) 1.50

Liver transplantation for hepatocellular carcinoma. Ann Surg Oncol (2008) 1.50

Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters. BMC Cancer (2009) 1.49

Prevention of recurrence after resection of hepatocellular carcinoma: a daunting challenge. Hepatology (2011) 1.47

Aedes aegypti (L.) and Aedes albopictus (Skuse) in Singapore City. 3. Population fluctuations. Bull World Health Organ (1971) 1.46

Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg (2002) 1.45

Reduced expression of chemokine receptors on peripheral blood lymphocytes in patients with hepatocellular carcinoma. Am J Gastroenterol (2004) 1.45

Oleosin isoforms of high and low molecular weights are present in the oil bodies of diverse seed species. Plant Physiol (1990) 1.45

Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. J Am Coll Surg (2008) 1.44

Roles of the Bloom's syndrome helicase in the maintenance of genome stability. Biochem Soc Trans (2005) 1.42

Aedes aegypti (L.) and Aedes albopictus (Skuse) in Singapore City. 5. Observations in relation to dengue haemorrhagic fever. Bull World Health Organ (1971) 1.42

DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival. J Biol Chem (2011) 1.40

Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. Mol Cell Proteomics (2007) 1.39

Pancreatic pleural effusion: an indication for emergency distal pancreatectomy and Roux-en-Y pancreatico-jejunostomy. J Pediatr Surg (1994) 1.38

The impact of psychological abuse by an intimate partner on the mental health of pregnant women. BJOG (2008) 1.37

Aedes aegypti (L.) and Aedes albopictus (Skuse) in Singapore City. 4. Competition between species. Bull World Health Organ (1971) 1.37

Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer. Gastroenterology (2006) 1.33

Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? Cancer Res (2011) 1.33

Images in cardiology. Giant coronary sinus and absent right superior vena cava. Heart (2000) 1.32

Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma. Hepatology (2009) 1.32

Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases. Clin Cancer Res (2005) 1.32

FTY720: a promising agent for treatment of metastatic hepatocellular carcinoma. Clin Cancer Res (2005) 1.29

96 weeks combination of adefovir dipivoxil plus emtricitabine vs. adefovir dipivoxil monotherapy in the treatment of chronic hepatitis B. J Hepatol (2007) 1.28

Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection. Am J Gastroenterol (2008) 1.28

Kidney claudin-19: localization in distal tubules and collecting ducts and dysregulation in polycystic renal disease. FEBS Lett (2006) 1.27

Predictive genes in adjacent normal tissue are preferentially altered by sCNV during tumorigenesis in liver cancer and may rate limiting. PLoS One (2011) 1.26

Applicability of intraoperative parathyroid hormone assay during thyroidectomy. Ann Surg (2002) 1.26

Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition. Cancer Res (2006) 1.25

Aortic aneurysm in patients with functionally normal or minimally stenotic bicuspid aortic valve. Am J Cardiol (1991) 1.25

Targeting YAP and Hippo signaling pathway in liver cancer. Expert Opin Ther Targets (2010) 1.24

Identification of new reference genes for the normalisation of canine osteoarthritic joint tissue transcripts from microarray data. BMC Mol Biol (2007) 1.24

Lupeol suppresses cisplatin-induced nuclear factor-kappaB activation in head and neck squamous cell carcinoma and inhibits local invasion and nodal metastasis in an orthotopic nude mouse model. Cancer Res (2007) 1.24